The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALECTOR INC | COM | 014442107 | 1,183,743 | 845,531 | SH | SOLE | 845,531 | 0 | 0 | ||
ALIGOS THERAPEUTICS INC | COM NEW | 01626L204 | 2,422,106 | 335,937 | SH | SOLE | 335,937 | 0 | 0 | ||
ANI PHARMACEUTICALS INC | COM | 00182C103 | 7,368,226 | 112,923 | SH | SOLE | 112,923 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 9,829,834 | 4,095,764 | SH | SOLE | 4,095,764 | 0 | 0 | ||
ANTERIS TECHNOLOGIES GLOBAL | COM | 03675P102 | 6,969,893 | 1,839,022 | SH | SOLE | 1,839,022 | 0 | 0 | ||
APREA THERAPEUTICS INC | COM NEW | 03836J201 | 472,134 | 279,369 | SH | SOLE | 279,369 | 0 | 0 | ||
AQUESTIVE THERAPEUTICS INC | COM | 03843E104 | 3,136,189 | 947,489 | SH | SOLE | 947,489 | 0 | 0 | ||
ARTIVION INC | COM | 228903100 | 4,936,690 | 158,736 | SH | SOLE | 158,736 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 1,705,852 | 318,256 | SH | SOLE | 318,256 | 0 | 0 | ||
ATYR PHARMA INC | COM NEW | 002120202 | 5,577 | 1,100 | SH | Put | SOLE | 1,100 | 0 | 0 | |
AVALO THERAPEUTICS INC | COM NEW | 05338F306 | 360,143 | 72,173 | SH | SOLE | 72,173 | 0 | 0 | ||
AVANOS MED INC | COM | 05350V106 | 3,535,512 | 288,849 | SH | SOLE | 288,849 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 12,374,517 | 225,114 | SH | SOLE | 225,114 | 0 | 0 | ||
BOUNDLESS BIO INC | COM | 10170A100 | 165,316 | 163,679 | SH | SOLE | 163,679 | 0 | 0 | ||
BRIGHT MINDS BIOSCIENCES INC | COM NEW | 10919W405 | 13,377,145 | 512,338 | SH | SOLE | 512,338 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 14,248,500 | 262,500 | SH | SOLE | 262,500 | 0 | 0 | ||
CONTEXT THERAPEUTICS INC | COM | 21077P108 | 879,040 | 1,341,636 | SH | SOLE | 1,341,636 | 0 | 0 | ||
DIANTHUS THERAPEUTICS INC | COM | 252828108 | 4,397,984 | 236,070 | SH | SOLE | 236,070 | 0 | 0 | ||
DISC MEDICINE INC | COM | 254604101 | 15,082,320 | 284,787 | SH | SOLE | 284,787 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 7,075,860 | 539,730 | SH | SOLE | 539,730 | 0 | 0 | ||
EMBECTA CORP | COMMON STOCK | 29082K105 | 302,028 | 31,169 | SH | SOLE | 31,169 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 1,351,531 | 178,774 | SH | SOLE | 178,774 | 0 | 0 | ||
ERASCA INC | COM | 29479A108 | 1,739,580 | 1,369,748 | SH | SOLE | 1,369,748 | 0 | 0 | ||
FOGHORN THERAPEUTICS INC | COM | 344174107 | 577,578 | 122,889 | SH | SOLE | 122,889 | 0 | 0 | ||
GLOBUS MED INC | CL A | 379577208 | 14,493,541 | 245,570 | SH | SOLE | 245,570 | 0 | 0 | ||
HUMACYTE INC | *W EXP 08/27/202 | 44486Q111 | 18,749 | 49,998 | SH | SOLE | 49,998 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 2,611,315 | 124,230 | SH | SOLE | 124,230 | 0 | 0 | ||
IDEXX LABS INC | COM | 45168D104 | 9,654,120 | 18,000 | SH | Put | SOLE | 18,000 | 0 | 0 | |
INMUNE BIO INC | COM | 45782T105 | 3,001,383 | 1,299,300 | SH | Put | SOLE | 1,299,300 | 0 | 0 | |
MAXIMUS INC | COM | 577933104 | 38,475,637 | 548,086 | SH | SOLE | 548,086 | 0 | 0 | ||
MBX BIOSCIENCES INC | COM | 55287L101 | 2,749,810 | 241,000 | SH | SOLE | 241,000 | 0 | 0 | ||
MERCK & CO INC | COM | 58933Y105 | 13,769,961 | 173,951 | SH | SOLE | 173,951 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 3,299,019 | 62,719 | SH | SOLE | 62,719 | 0 | 0 | ||
MODULAR MED INC | COM NEW | 60785L207 | 585,439 | 785,824 | SH | SOLE | 785,824 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 12,660,125 | 100,725 | SH | SOLE | 100,725 | 0 | 0 | ||
NEUROONE MED TECHNOLOGIES CO | COM NEW | 64130M209 | 2,390,101 | 3,523,663 | SH | SOLE | 3,523,663 | 0 | 0 | ||
NEXTCURE INC | COM | 65343E108 | 60,398 | 131,300 | SH | SOLE | 131,300 | 0 | 0 | ||
NYXOAH S A | SHS | B6S7WD106 | 380,276 | 50,839 | SH | SOLE | 50,839 | 0 | 0 | ||
OVID THERAPEUTICS INC | COM | 690469101 | 736,337 | 2,232,000 | SH | SOLE | 2,232,000 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 3,959,520 | 3,735,396 | SH | SOLE | 3,735,396 | 0 | 0 | ||
PROQR THERAPEUTICS N V | SHS EURO | N71542109 | 4,233,284 | 2,075,139 | SH | SOLE | 2,075,139 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 77313F114 | 13,620 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
SANOFI | SPONSORED ADR | 80105N105 | 9,058,125 | 187,500 | SH | SOLE | 187,500 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 1,657,220 | 726,851 | SH | SOLE | 726,851 | 0 | 0 | ||
SENSEONICS HLDGS INC | COM | 81727U105 | 2,311,635 | 4,852,298 | SH | SOLE | 4,852,298 | 0 | 0 | ||
SEPTERNA INC | COM | 81734D104 | 6,177,478 | 584,435 | SH | SOLE | 584,435 | 0 | 0 | ||
TELA BIO INC | COM | 872381108 | 1,234,422 | 636,300 | SH | SOLE | 636,300 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 37,673 | 10,100 | SH | SOLE | 10,100 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 1,808,708 | 122,210 | SH | SOLE | 122,210 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | 7,754,322 | 810,274 | SH | SOLE | 810,274 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 2,799,043 | 1,307,964 | SH | SOLE | 1,307,964 | 0 | 0 | ||
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 2,410,849 | 478,343 | SH | SOLE | 478,343 | 0 | 0 |